References
Abbas, A. K., et al. (2015).Cellular and molecular immunology. Elsevier.
Aisyah, D. N., et al. (2020). A spatial-temporal description of the SARS-COV-2 infections in Indonesia
during the first six months of outbreak. PLOS ONE, 15(12).
https://doi.org/10.1371/journal.pone.0243703
Altschul, S. F., et al. (1990). Basic local alignment search tool.Journal of Molecular Biology,215(3), 403–410.https://doi.org/10.1016/s0022-2836(05)80360-2
Arts, R. J. W., et al. (2018). BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity.Cell Host & Microbe, 23(1).https://doi.org/10.1016/j.chom.2017.12.010
Birra, D., et al. (2020). Covid 19: A clue from innate immunity. Immunologic Research, 68(3), 161–168.https://doi.org/10.1007/s12026-020-09137-5
Boechat, J. L., Chora, I., Morais, A., & Delgado, L. (2021). The immune response to SARS-COV-2 and COVID-19 immunopathology – current perspectives. Pulmonology, 27(5), 423–437.
https://doi.org/10.1016/j.pulmoe.2021.03.008
Brant, A. C., et al. (2021). SARS-COV-2: From its discovery to genome structure, transcription, and replication.Cell & Bioscience,11(1).https://doi.org/10.1186/s13578-021-00643-z
Comunale, B. A., et al. (2021). Poliovirus vaccination induces a humoral immune response that cross reacts with SARS-COV-2.Frontiers in Medicine,8.https://doi.org/10.3389/fmed.2021.710010
Fisker, A. (2022). OPV as potential protection against COVID-19 - Full Text View. Full Text View -
ClinicalTrials.gov. Retrieved May 23, 2022, from
https://clinicaltrials.gov/ct2/show/NCT04445428
25
Ganesh, B., et al. (2021). Epidemiology and pathobiology of SARS-COV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives.
Clinical Epidemiology and Global Health, 10, 100694.
https://doi.org/10.1016/j.cegh.2020.100694
Gonzalez-Galarza, et al. (2019). Allele frequency net database (AFND) 2020 update: Gold-standard data classification, open access genotype data and New Query Tools.Nucleic Acids Research.
https://doi.org/10.1093/nar/gkz1029
Grifoni, A., et al. (2020). Targets of T cell responses to SARS-COV-2 coronavirus in humans with
covid-19 disease and unexposed individuals. Cell, 181(7).
https://doi.org/10.1016/j.cell.2020.05.015
Haddad-Boubaker, S., et al. (2021). In silico comparative study of SARS-COV-2 proteins and antigenic proteins in BCG, OPV, MMR and other vaccines: Evidence of a possible putative protective effect.BMC Bioinformatics,22(1).https://doi.org/10.1186/s12859-021-04045-3
Harrison, A. G., Lin, T., & Wang, P. (2020). Mechanisms of SARS-COV-2 transmission and
pathogenesis. Trends in Immunology, 41(12), 1100–1115.
https://doi.org/10.1016/j.it.2020.10.004
Hikmawati, I., & Setiyabudi, R. (2021). Epidemiology of covid-19 in Indonesia: Common source and propagated source as a cause for outbreaks.The Journal of Infection in Developing Countries, 15(05), 646–652.https://doi.org/10.3855/jidc.14240
Holland, C. J., Cole, D. K., & Godkin, A. (2013). Re-directing CD4+ T cell responses with the flanking residues of MHC class II-bound peptides: The core is not enough.Frontiers in Immunology,4.
https://doi.org/10.3389/fimmu.2013.00172
Kissler, S. M., et al. (2020). Projecting the transmission dynamics of SARS-COV-2 through the post
26
pandemic period.Science,368(6493), 860–868.https://doi.org/10.1126/science.abb5793
Lipsitch, M., Grad, Y. H., Sette, A., & Crotty, S. (2020). Cross-reactive memory T cells and herd immunity to SARS-COV-2. Nature Reviews Immunology, 20(11), 709–713.
https://doi.org/10.1038/s41577-020-00460-4
Lundberg, L., et al. (2021). Recent MMR vaccination in health care workers and covid-19: A test
negative case-control study. Vaccine, 39(32), 4414–4418.
https://doi.org/10.1016/j.vaccine.2021.06.045
Mak, T. W., & Saunders, M. E. (2006). Vaccines and clinical immunization. The Immune Response, 695–749.https://doi.org/10.1016/b978-012088451-3.50025-9
Malave Sanchez, M., Saleeb, P., Kottilil, S., & Mathur, P. (2021). Oral polio vaccine to protect against COVID-19: Out of the box strategies? Open Forum Infectious Diseases, 8(8).
https://doi.org/10.1093/ofid/ofab367
Milinski, M., et al. (2005). Mate choice decisions of stickleback females predictably modified by MHC peptide ligands. Proceedings of the National Academy of Sciences, 102(12), 4414–4418.
https://doi.org/10.1073/pnas.0408264102
Murphy, K., & Weaver, C. (2017).Janeway's Immunobiology. Garland Science, Taylor & Francis Group.
Murray, M. (2021).BCG against covid-19 for prevention and amelioration of severity trial (BAC to the past) - full text view. Full Text View - ClinicalTrials.gov. Retrieved May 23, 2022, from https://clinicaltrials.gov/ct2/show/NCT04534803
Naqvi, A. A., et al. (2020). Insights into SARS-COV-2 genome, structure, evolution, pathogenesis and therapies: Structural Genomics Approach. Biochimica Et Biophysica Acta (BBA) - Molecular Basis of Disease,1866(10), 165878.https://doi.org/10.1016/j.bbadis.2020.165878
27
NCBI Resource Coordinators (2016). Database resources of the National Center for Biotechnology Information.Nucleic acids research,44(D1), D7–D19.https://doi.org/10.1093/nar/gkv1290
Reynisson, B., et al. (2020). Improved prediction of MHC II antigen presentation through integration and motif deconvolution of mass spectrometry MHC eluted ligand data.Journal of Proteome Research,19(6), 2304–2315.https://doi.org/10.1021/acs.jproteome.9b00874
Rothan, H. A., & Byrareddy, S. N. (2020). The epidemiology and pathogenesis of coronavirus disease
(COVID-19) outbreak. Journal of Autoimmunity, 109, 102433.
https://doi.org/10.1016/j.jaut.2020.102433
Ryu, W.-S. (2017). New emerging viruses.Molecular Virology of Human Pathogenic Viruses, 289–302.
https://doi.org/10.1016/b978-0-12-800838-6.00021-7
Sette, A., & Crotty, S. (2021). Adaptive immunity to SARS-COV-2 and COVID-19.Cell,184(4), 861–880.
https://doi.org/10.1016/j.cell.2021.01.007
Shah, V. K., et al. (2020). Overview of immune response during SARS-COV-2 infection: Lessons from the past.Frontiers in Immunology,11.https://doi.org/10.3389/fimmu.2020.01949
Sidiq, K. R., Sabir, D. K., Ali, S. M., & Kodzius, R. (2020). Does early childhood vaccination protect
against covid-19? Frontiers in Molecular Biosciences, 7.
https://doi.org/10.3389/fmolb.2020.00120
Stranzl, T., et al. (2010). NetCTLpan: Pan-specific MHC class I pathway epitope predictions.
Immunogenetics,62(6), 357–368.https://doi.org/10.1007/s00251-010-0441-4
Tomita, Y., Sato, R., Ikeda, T., & Sakagami, T. (2020). BCG vaccine may Generate cross-reactive T cells AGAINST Sars-cov-2: In silico analyses and a hypothesis. Vaccine, 38(41), 6352–6356.
https://doi.org/10.1016/j.vaccine.2020.08.045
28
